Your SlideShare is downloading. ×
Obsessive compulsive disorder – pipeline review, h2 2012
Upcoming SlideShare
Loading in...5

Thanks for flagging this SlideShare!

Oops! An error has occurred.


Introducing the official SlideShare app

Stunning, full-screen experience for iPhone and Android

Text the download link to your phone

Standard text messaging rates apply

Obsessive compulsive disorder – pipeline review, h2 2012


Published on

20% Off | || Obsessive compulsive disorder – pipeline review, h2 2012

20% Off | || Obsessive compulsive disorder – pipeline review, h2 2012

Published in: News & Politics

  • Be the first to comment

  • Be the first to like this

No Downloads
Total Views
On Slideshare
From Embeds
Number of Embeds
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

No notes for slide


  • 1. You can also request for sample page of abovemention reports on
  • 2. Pages : 59PDF - $ 2000 | Site Licence - $ 4000 $ | Enterprise License - $6000 |20% Off on above 1000$ Reports25% off on purchase of 2 reports and 30% on purchase of3 or more reports.Discount till 31st Dec. 2012.
  • 3. Summary Global Markets Direct’s, Obsessive-Compulsive Disorder - Pipeline Review,H2 2012, provides an overview of the indication’s therapeutic pipeline. Thisreport provides information on the therapeutic development for Obsessive-Compulsive Disorder, complete with latest updates, and special features onlate-stage and discontinued projects. It also reviews key players involved inthe therapeutic development for Obsessive-Compulsive Disorder. Obsessive-Compulsive Disorder - Pipeline Review, Half Year is built using data andinformation sourced from Global Markets Direct’s proprietary databases,Company/University websites, SEC filings, investor presentations andfeatured press releases from company/university sites and industry-specificthird party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based onthe availability and relevance of data for the indicated disease.
  • 4. Scope - A snapshot of the global therapeutic scenario for Obsessive-CompulsiveDisorder.- A review of the Obsessive-Compulsive Disorder products under developmentby companies and universities/research institutes based on information derivedfrom company and industry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.Reasons to buy- Identify and understand important and diverse types of therapeutics underdevelopment for Obsessive-Compulsive Disorder.- Identify emerging players with potentially strong product portfolio and designeffective counter-strategies to gain competitive advantage.- Plan mergers and acquisitions effectively by identifying players of the mostpromising pipeline.
  • 5. Table of Contents : List of Tables 5List of Figures 5Introduction 6Global Markets Direct Report Coverage 6Obsessive-Compulsive Disorder Overview 7Therapeutics Development 8An Overview of Pipeline Products for Obsessive-Compulsive Disorder 8Obsessive-Compulsive Disorder Therapeutics under Development byCompanies 10Obsessive-Compulsive Disorder Therapeutics under Investigation byUniversities/Institutes 11Late Stage Products 12Comparative Analysis 12Mid Clinical Stage Products 13Comparative Analysis 13Pre-Clinical Stage Products 14Comparative Analysis 14Obsessive-Compulsive Disorder Therapeutics – Products underDevelopment by Companies 15…………………………
  • 6. Please follow link if you want More RelatedReports :Pipeline Review, H2 2012, H2 2012&PubId=&pagenum=1
  • 7. Related Reports:Generalized Seizures – Pipeline Review, H2 2012Cataract – Pipeline Review, H2 2012Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H22012Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012Erosive Oral Lichen Planus – Pipeline Review, H2 2012Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012Blepharitis – Pipeline Review, H2 2012Hypoparathyroidism – Pipeline Review, H2 2012Lyme Disease – Pipeline Review, H2 2012Optic Nerve Injury – Pipeline Review, H2 2012Auto Inflammatory Disease – Pipeline Review, H2 2012
  • 8. For More details about above & otherReports plz contact :LavanyaAarkstore.comContact: Marketing team Mob.No.918149852585Email: ,discount@aarkstore.comURL: http://www.aarkstore.com